<?xml version="1.0" encoding="UTF-8"?>
<ref id="B133">
 <label>133.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kallen</surname>
    <given-names>KJ</given-names>
   </name>
   <name>
    <surname>Heidenreich</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Schnee</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Petsch</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Schlake</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Thess</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>A novel, disruptive vaccination technology: self-adjuvanted RNActive
   <sup>®</sup> vaccines
  </article-title>. 
  <source>Hum Vaccin Immunother.</source> (
  <year>2013</year>) 
  <volume>9</volume>:
  <fpage>2263</fpage>–
  <lpage>76</lpage>. 
  <pub-id pub-id-type="doi">10.4161/hv.25181</pub-id>
  <?supplied-pmid 23921513?>
  <pub-id pub-id-type="pmid">23921513</pub-id>
 </mixed-citation>
</ref>
